In March, reportedly, India's central bank had plans to ask lenders to follow stricter underwriting processes for gold loans and monitor the end-use of funds
Tata Steel's shares fell as much as 3.82 per cent during the day to ₹125.3 per share
Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.
In the past five days, the BSE IT index has slipped nearly 10 per cent, and it has tanked 26 per cent thus far in calendar year 2025.
The floor price of the QIP was set at ₹1,019.25 per share which implies 3 per cent premium over Tuesday's closing at ₹988.45 per share on BSE
In the last 25 years, the Nifty spent 64 or more days below its 200-DMA only on 10 instances, shows data. Here's what the past analysis on Nifty's negative trend reveals.
Support for the Nifty has moved up to 22,341, while resistance is placed in the range of 22,800-22,900
From the sectoral front, the Nifty PSU Bank index added 2.6 per cent ahead of the announcement of the policy decision by the RBI's MPC scheduled for tomorrow, April 8, 2025
The company's stock rose as much as 6.57 per cent during the day to ₹207.7 per share, the biggest intraday gain since March 19 this year
On March 31, 2025, ITC had signed a Business Transfer Agreement to acquire the pulp and paper undertaking of Aditya Birla Real Estate Limited. Analysts view this development as a positive.
Technically, HPCL, BPCL stock seem to be favourably placed on the charts with key support at ₹ 324 and ₹ 255, respectively. IOC stock chart however flags a caution sign.
On Monday, April 7, 2025, the stock price of Delhivery had gained 4 per cent to ₹268.45 after the company announced its acquisition of Ecom Express for ₹1,400 crore in an all-cash deal.
In FY25 the company's pre-sales for stood at ₹3,028 crore as compared to ₹2,266 crore in FY24, showing a growth of 34 per cent
Reports suggest that India's overnight indexed swap (OIS) rates signal a bigger reduction or a change in its stance.
The stock gained after the company secured the cluster redevelopment rights in Borivali West, Mumbai with an estimated gross development value (GDV) of ₹865 crore
Synergies from Coromandel and NACL's combined sourcing, consolidation of R&D, benefits from the management's expertise and financial reputation shall improve NACL's business profile.
In Q4FY25, the company's consolidated revenue increased by 5.1 per cent as compared to the same quarter in the previous financial year, contributing to full-year growth of 25.9 per cent
Shriram Finance's credit cost is expected to improve marginally to about 1.9% of average loans over the next couple of years from 2.1% currently.
Global Health's stock rose as much as 3.91 per cent during the day to ₹1,242.7 per share, the biggest intraday gain since March 18 this year
The NSE Nifty 50 has been trading above the psychological 20,000-mark since December 2023. Here are the key levels to watch out for on the index.